an ET(A) receptor antagonist and antihypertensive agent; studied for use in pulmonary arterial hypertension
Also Known As:
(+)-(2S)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic acid; (+)-ambrisentan; (+-)-ambrisentan; (-)-ambrisentan; (R)-ambrisentan; (S)-ambrisentan; BSF 208075; BSF-208075; BSF208075; GSK 1325760; GSK 1325760A; GSK-1325760; GSK-1325760A; GSK1325760; GSK1325760A; LU 208075; LU-208075; LU208075; Letairis; Volibris; ambrisentan, (+-)-; ambrisentan, (-)-; ambrisentan, (R)-